Centralized review offers promise for the clinician, the pathologist, and the patient with newly diagnosed lymphoma
- PMID: 21343557
- PMCID: PMC6363336
- DOI: 10.1200/JCO.2010.34.2741
Centralized review offers promise for the clinician, the pathologist, and the patient with newly diagnosed lymphoma
Conflict of interest statement
AUTHOR’S DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST
The author(s) indicated no potential conflicts of interest.
Comment on
-
Importance of expert central review in the diagnosis of lymphoid malignancies in a regional cancer network.J Clin Oncol. 2011 Apr 10;29(11):1431-5. doi: 10.1200/JCO.2010.31.2223. Epub 2011 Feb 22. J Clin Oncol. 2011. PMID: 21343555
References
-
- Kim H, Zelman RJ, Fox MA, et al.: Pathology Panel for Lymphoma Clinical Studies: A comprehensive analysis of cases accumulated since its inception. J Natl Cancer Inst 68:43–67, 1982 - PubMed
-
- DeVita V, Rappaport H, Frei E: Announcement of formation of: The Lymphoma Task Force and Pathology Reference Center. Cancer 22:1087–1088, 1968
-
- Rosenwald A, Wright G, Chan WC, et al.: The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346:1937–1947, 2002 - PubMed
-
- Hummel M, Bentink S, Berger H, et al.: A biologic definition of Burkitt’s lymphoma from transcriptional and genomic profiling. N Engl J Med 354:2419–2430, 2006 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical